We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
-0.59%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$182B
AUM Growth
-$6.94B
Cap. Flow
-$2.75B
Cap. Flow %
-1.52%
Top 10 Hldgs %
16.96%
Holding
4,732
New
306
Increased
1,885
Reduced
1,854
Closed
476

Sector Composition

Rank Sector Weight
1 Technology 15.32%
2 Healthcare 10.78%
3 Financials 8.3%
4 Consumer Discretionary 7.44%
5 Communication Services 5.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EL icon
3476
PUT
Estee Lauder
EL
$31.5B
$690K ﹤0.01%
2,300
-14,600
-86% -$4.77M
SKYW icon
3477
Skywest
SKYW
$4.6B
$690K ﹤0.01%
13,968
-9,805
-41% -$427K
AORT icon
3478
Artivion
AORT
$1.27B
$689K ﹤0.01%
30,896
-11,308
-27% -$291K
VRTX icon
3479
CALL
Vertex Pharmaceuticals
VRTX
$123B
$689K ﹤0.01%
3,800
-1,300
-25% -$254K
RSI icon
3480
Rush Street Interactive
RSI
$2.67B
$688K ﹤0.01%
35,862
+8,241
+30% +$113K
FXA icon
3481
Invesco CurrencyShares Australian Dollar Trust
FXA
$97.8M
$686K ﹤0.01%
9,560
+3,280
+52% +$239K
GEO icon
3482
The GEO Group
GEO
$4.2B
$686K ﹤0.01%
91,812
-22,171
-19% -$163K
UI icon
3483
Ubiquiti
UI
$34.4B
$685K ﹤0.01%
+2,295
New +$709K
INVX
3484
Innovex International
INVX
$2.13B
$685K ﹤0.01%
27,245
-2,781
-9% -$73.9K
IJH icon
3485
iShares Core S&P Mid-Cap ETF
IJH
$125B
$684K ﹤0.01%
12,990
-5,440
-30% -$293K
ISEE
3486
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$683K ﹤0.01%
42,029
+12,778
+44% +$139K
AKRO
3487
DELISTED
Akero Therapeutics
AKRO
$682K ﹤0.01%
30,572
+20,235
+196% +$458K
SMP icon
3488
Standard Motor Products
SMP
$881M
$682K ﹤0.01%
15,613
-1,226
-7% -$52.6K
SILJ icon
3489
Amplify Junior Silver Miners ETF
SILJ
$3.67B
$677K ﹤0.01%
57,327
+15,193
+36% +$204K
MORF
3490
DELISTED
Morphic Holding, Inc. Common Stock
MORF
$677K ﹤0.01%
11,949
+970
+9% +$58.7K
GRC icon
3491
Gorman-Rupp
GRC
$2.25B
$676K ﹤0.01%
18,872
+1,681
+10% +$59.6K
IGIB icon
3492
iShares 5-10 Year Investment Grade Corporate Bond ETF
IGIB
$18.6B
$673K ﹤0.01%
11,202
-5,602
-33% -$340K
NGD
3493
DELISTED
New Gold Inc
NGD
$673K ﹤0.01%
635,022
-37,496
-6% -$51.6K
NTUS
3494
DELISTED
Natus Medical Inc
NTUS
$673K ﹤0.01%
26,833
-4,909
-15% -$125K
REX icon
3495
REX American Resources
REX
$1.45B
$670K ﹤0.01%
50,370
-5,412
-10% -$73.1K
Z icon
3496
CALL
Zillow
Z
$8.26B
$670K ﹤0.01%
7,600
+500
+7% +$50.6K
SRCE icon
3497
1st Source
SRCE
$2.17B
$669K ﹤0.01%
14,168
+2,544
+22% +$116K
INSG icon
3498
Inseego
INSG
$121M
$667K ﹤0.01%
10,017
-18,167
-64% -$1.52M
TRC icon
3499
Tejon Ranch
TRC
$444M
$667K ﹤0.01%
37,587
+1,920
+5% +$34.1K
KLRS
3500
Kalaris Therapeutics
KLRS
$99.7M
$667K ﹤0.01%
1,156
+361
+45% +$167K

Similar funds

Credit Suisse's Q3 2021 Portfolio in Review

As of Q3 2021, Credit Suisse held 4,732 positions worth $182B, down 3.7% from $189B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Credit Suisse's Q3 2021 filing shows 306 new, 1,885 increased, 1,854 reduced and 476 closed positions. Its largest new stake was IHS Markit Ltd. Common Shares: 1,723,127 shares worth $201M. The largest sale was Twitter, Inc., an estimated $570M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.

  • Credit Suisse's largest Q3 2021 buy was IHS Markit Ltd. Common Shares: 1,723,127 shares worth $201M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $598M increase.
  • Credit Suisse's biggest Q3 2021 reduction was Twitter, Inc., cutting an estimated $570M.
  • Credit Suisse fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $321M.
  • Credit Suisse's ten largest holdings make up 17% of its $182B portfolio in Q3 2021.
  • Credit Suisse opened 306 new positions and closed 476 in Q3 2021.
  • Credit Suisse's portfolio value fell 3.7% quarter-over-quarter to $182B.

Based on Credit Suisse's 13F filing for Q3 2021, filed 12 Nov 2021.